The CARE reporting guideline for writing clinical case report articles
How to use this reporting guideline
You can use reporting guidelines throughout your research process.
- When writing: Consider using a writing guide to draft your manuscript or protocol.
- After writing: Complete a checklist and include it with your journal submission.
- To learn: Consult the guidance whenever you need it.
However you use CARE, please cite it.
Applicability criteria
Summary of guidance
Although you should describe all items below, you can decide how to order and prioritize items most relevant to your study, findings, context, and readership whilst keeping your writing concise. You can read how CARE was developed in the FAQs.
Item name | What to write |
Sections | |
1. Title | The area of focus and “case report” should appear in the title. |
2. Keywords | The key elements of this case in 2–5 words. |
3. Abstract | 3a – Introduction: What does this case add? 3b – Case presentation:
3c – Conclusion: What are the main “take-away” lessons from this case? |
4. Introduction | Brief background summary of the case referencing the relevant medical literature. |
5a. Patient information | 5a – Demographic information of the patient (age, gender, ethnicity, occupation). 5b – Main symptoms of the patient (chief complaint). 5c – Medical, family, and psychosocial history—including lifestyle and genetic information whenever possible, details about relevant comorbidities, and past interv… |
6. Clinical findings | Describe the relevant physical examination (PE) findings. |
7. Timeline | Depict important date and times in this case (table or figure). |
8. Diagnostic assessment | 8a – Diagnostic methods (e.g., physical examination, laboratory testing, imaging, questionnaires) 8b – Diagnostic challenges (e.g., financial, language, or cultural) 8c – Diagnostic reasoning including other diagnoses considered 8d – Prognostic characteristics (e.g., staging) where applicable. |
9. Therapeutic Intervention | 9a – Types of intervention (e.g., pharmacologic, surgical, preventive, self-care) 9b – Administration (e.g., dosage, strength, duration) 9c – Changes in intervention (with rationale). |
10. Follow up and outcomes | 10a – Clinician and patient-assessed outcomes 10b – Important follow-up test results (positive and negative) 10c – Intervention adherence and tolerability (and how this was assessed) 10d – Adverse and unanticipated events. |
11. Discussion | Discussion (including conclusion): 11a – Strengths and limitations of the management of this case 11b – Relevant medical literature 11c – Rationale for conclusions (including assessment of cause and effect) 11d – Main “take-away” lessons of this case report. |
12. Patient perspective | When appropriate patients should share their perspectives on the treatments they received. |
13. Informed consent | Did the patient give informed consent? Please provide if requested. |
We like publishing transparent research because we think it’s more likely to be used and cited. That’s why we ask authors to use reporting guidelines.
Robin Lavery
Editor, International Journal of World Medicine